¸Þ´º ¹Ù·Î°¡±â º»¹® ¹Ù·Î°¡±â
Å©°Ô±ÛÀÚ Å©±âÀÛ°ÔÇÁ¸°Æ®
Home  > Áø·á¾È³» > Áø·á°ú/ÀÇ·áÁø > ÀÇ·áÁø¼Ò°³

ÀÇ·áÁø¼Ò°³

½ÉÀå³»°ú

³í¹®
1. Influence of Socioeconomic Status on the Presence of Obstructive Coronary Artery Disease and Cardiovascular Outcomes in Patients Undergoing Invasive Coronary Angiography. Healthcare 2024.
2. New onset diabetes mellitus and cardiovascular outcomes according to statin intensity in patients after drug-eluting stent implantation in Asian patients. Scientific reports 2023.
3. Lifestyle Modification in the Management of Metabolic Syndrome: Statement From Korean Society of CardioMetabolic Syndrome (KSCMS). Korean Circ J 2022.
4. Association between Socioeconomic Status and Metabolic Syndrome in Korean Adults: Data from the Korean National Health and Nutrition Examination Survey. Cardiometab Syndr J 2021.
5. Association between histological severity of Helicobacter pylori infection and cardiovascular risk scores in the Korean population. Atherosclerosis 2021.
6. Long-term efficacy of vasodilating ¥â-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry. The Korean journal of internal medicine 2021.
7. Association of the Serum Osteoprotegerin Level With Target Organ Damage in Patients at High Risk of Coronary Artery Disease. Circulation journal 2020.
8. Association between invasively measured aortic pulse pressure and orthostatic hypotension in patients undergoing invasive coronary angiography. Journal of hypertension 2019.
9. Sex Differences in Long-Term Clinical Outcomes in Patients Hospitalized for Acute Heart Failure: A Report from the Korean Heart Failure Registry. Journal of Women's Health 2019.
10. Benefit of Vasodilating ¥â?Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study. Journal of the American Heart Association 2017.

¢¹ ÇÐȸ¹ßÇ¥
1. Influence of socioeconomic status on the presence of obstructive coronary artery disease and cardiovascular outcomes in patients undergoing invasive coronary angiography. European society of cardiology congress, 2023.
2. Update in obesity treatment, diet pattern and contents. ´ëÇѽÉÀåÇÐȸ Ãß°èÇмú´ëȸ 2023.
3. Sex difference in clinical characteristics and outcomes of patients with heart failure. ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¾ö 2023.
4. How to improve arterial stiffness. ´ëÇѰíÇ÷¾ÐÇÐȸ Ãá°èÇмú´ëȸ 2023.
5. Methods for assessing adherence to hypertension treatment. ´ëÇѰíÇ÷¾ÐÇÐȸ Ãá°èÇмú´ëȸ 2023.
6. Precision timing of food intake and exercise in cardiometabolic disease. Asia-pacific cardiometabolic syndrome congress 2023.
7. Management Comorbidities in Diabetes: ´ç´¢º´ ȯÀÚÀÇ ½ÉÇ÷°ü À§Çè¿ä¼Ò °ü¸®¹ý. ´ëÇѽÉÀåÇÐȸ Ãß°èÇмú´ëȸ 2022.
8. First-line Beta-Blocker Monotherapy in Hypertensive Patients. ´ëÇѰíÇ÷¾ÐÇÐȸ Ãß°èÇмú´ëȸ 2022.
9. Pleiotropic Effects of Cardiovascular Drugs: Ezetimibe. Asia-pacific cardiometabolic syndrome congress 2022.
10. Cardiovascular outcomes and new onset of diabetes mellitus in patients after drug-eluting stent implantation in Asian patients: high intensity versus moderate intensity statin therapy. Asia-pacific cardiometabolic syndrome congress 2021.
Àú¼­
1. ¿©¼º½ÉÀåÁúȯ. ´ëÇÑÀÇÇм­Àû 2021.